ArticleArthroplasty (London, England)2026
Generalized joint hypermobility and functional recovery after THA for unilateral Hartofilakidis type C developmental dysplasia of the hip: a retrospective cohort study.
Article in Arthroplasty (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundGeneralized joint hypermobility (GJH) is common in developmental dysplasia of the hip (DDH) and may affect recovery after total hip arthroplasty (THA) for Hartofilakidis type C, but its impact on the trajectory of postoperative functional recovery in this severe subgroup has not been clearly characterized.
methodsWe retrospectively reviewed patients aged 18-40 years who underwent THA for unilateral Hartofilakidis type C DDH (2018-2023). GJH was defined as a Beighton score ≥ 5. All procedures used a direct anterior approach with proximal femoral osteotomy for exposure and selective femoral shortening at the lesser trochanter level when reduction would otherwise impose excessive neurovascular tension or unacceptable residual leg-length discrepancy (LLD). Radiographic parameters and LLD were assessed. Harris Hip Score (HHS) was recorded preoperatively and at 1, 3, 6, and 12 months. Longitudinal HHS was analysed using a linear mixed-effects model; effect sizes were quantified by Cohen's d and partial η
resultsFifty-eight patients were included (21 GJH, 37 non-GJH). Postoperative LLD was reduced without a between-group difference. Cup position at 6 months was similar; femoral offset tended to be higher in GJH (p = 0.057). Femoral shortening distance was smaller in GJH (p < 0.001). Observed HHS was lower in GJH at 1-6 months (p < 0.001) but similar at 12 months. The linear mixed-effects model (LMM) showed significant time, group, and time × group effects (p < 0.001). Adjusted between-group differences were largest at 1 month and progressively diminished, becoming non-significant at 12 months. One dislocation occurred in the GJH group; no revisions were required.
conclusionsIn young adults with unilateral Hartofilakidis type C DDH, GJH did not compromise 12-month hip function after THA but was associated with a slower early recovery trajectory, with the largest deficit during the first 1-3 postoperative months.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.